Experimental cell shot aims to boost shoulder tear recovery
NCT ID NCT04057833
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This early-phase trial tests whether adding special cells (E-CEL UVEC) to standard rotator cuff surgery is safe and possible. About 20 adults aged 45-70 with full-thickness tears will receive the cells at the repair site. The main goal is to check for short-term side effects, not yet to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TEARS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital for Special Surgery
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.